PNPase knockout results in mtDNA loss and an altered metabolic gene expression program

dc.contributor.authorShimada, Eriko
dc.contributor.authorAhsan, Fasih M.
dc.contributor.authorNili, Mahta
dc.contributor.authorHuang, Dian
dc.contributor.authorAtamdede, Sean
dc.contributor.authorTeSlaa, Tara
dc.contributor.authorCase, Dana
dc.contributor.authorYu, Xiang
dc.contributor.authorGregory, Brian D.
dc.contributor.authorPerrin, Benjamin J.
dc.contributor.authorKoehler, Carla M.
dc.contributor.authorTeitell, Michael A.
dc.contributor.departmentBiology, School of Scienceen_US
dc.date.accessioned2019-05-21T14:10:09Z
dc.date.available2019-05-21T14:10:09Z
dc.date.issued2018-07-19
dc.description.abstractPolynucleotide phosphorylase (PNPase) is an essential mitochondria-localized exoribonuclease implicated in multiple biological processes and human disorders. To reveal role(s) for PNPase in mitochondria, we established PNPase knockout (PKO) systems by first shifting culture conditions to enable cell growth with defective respiration. Interestingly, PKO established in mouse embryonic fibroblasts (MEFs) resulted in the loss of mitochondrial DNA (mtDNA). The transcriptional profile of PKO cells was similar to rho0 mtDNA deleted cells, with perturbations in cholesterol (FDR = 6.35 x 10-13), lipid (FDR = 3.21 x 10-11), and secondary alcohol (FDR = 1.04x10-12) metabolic pathway gene expression compared to wild type parental (TM6) MEFs. Transcriptome analysis indicates processes related to axonogenesis (FDR = 4.49 x 10-3), axon development (FDR = 4.74 x 10-3), and axonal guidance (FDR = 4.74 x 10-3) were overrepresented in PKO cells, consistent with previous studies detailing causative PNPase mutations in delayed myelination, hearing loss, encephalomyopathy, and chorioretinal defects in humans. Overrepresentation analysis revealed alterations in metabolic pathways in both PKO and rho0 cells. Therefore, we assessed the correlation of genes implicated in cell cycle progression and total metabolism and observed a strong positive correlation between PKO cells and rho0 MEFs compared to TM6 MEFs. We quantified the normalized biomass accumulation rate of PKO clones at 1.7% (SD ± 2.0%) and 2.4% (SD ± 1.6%) per hour, which was lower than TM6 cells at 3.3% (SD ± 3.5%) per hour. Furthermore, PKO in mouse inner ear hair cells caused progressive hearing loss that parallels human familial hearing loss previously linked to mutations in PNPase. Combined, our study reports that knockout of a mitochondrial nuclease results in mtDNA loss and suggests that mtDNA maintenance could provide a unifying connection for the large number of biological activities reported for PNPase.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationShimada, E., Ahsan, F. M., Nili, M., Huang, D., Atamdede, S., TeSlaa, T., … Teitell, M. A. (2018). PNPase knockout results in mtDNA loss and an altered metabolic gene expression program. PloS one, 13(7), e0200925. doi:10.1371/journal.pone.0200925en_US
dc.identifier.urihttps://hdl.handle.net/1805/19405
dc.language.isoen_USen_US
dc.publisherPublic Library of Scienceen_US
dc.relation.isversionof10.1371/journal.pone.0200925en_US
dc.relation.journalPloS oneen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.sourcePMCen_US
dc.subjectBasic Helix-Loop-Helix Transcription Factorsen_US
dc.subjectCell Cycleen_US
dc.subjectDNA, Mitochondrialen_US
dc.subjectGene Expression Regulationen_US
dc.subjectHearing Lossen_US
dc.subjectMice, Inbred C57BLen_US
dc.subjectMice, Knockouten_US
dc.subjectMitochondriaen_US
dc.subjectPolyribonucleotide Nucleotidyltransferaseen_US
dc.titlePNPase knockout results in mtDNA loss and an altered metabolic gene expression programen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pone.0200925.pdf
Size:
5.84 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: